July 5, 2007 -- An experimental HIV drug called etravirine may help treat drug-resistant HIV as part of an HIV drug "cocktail" that also includes the HIV medication Prezista.
"This study is one of the most significant worldwide HIV/AIDS clinical trials in recent years," says researcher William Towner, MD, of Kaiser Permanente Southern California, in a Kaiser Permanente news release.
Towner is the medical director of Kaiser Permanente Southern California's HIV/AIDS Research Trials. He is also the Kaiser Permanente Southern California regional HIV/AIDS physician coordinator. read more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment